Celine Sze Ling Chui Selected Research

BNT162 Vaccine

12/2022	Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study.
12/2022	Lack of inflammatory bowel disease flare-up following two-dose BNT162b2 vaccine: a population-based cohort study.
11/2022	Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines.
8/2022	Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study.
6/2022	mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell's palsy: a nested case control and self-controlled case series study.
4/2022	Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control study.
3/2022	Comparing self-reported reactogenicity between adolescents and adults following the use of BNT162b2 (Pfizer-BioNTech) messenger RNA COVID-19 vaccine: a prospective cohort study.
1/2022	Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study.
1/2022	Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
1/2022	Post-Covid-19-vaccination adverse events and healthcare utilization among individuals with or without previous SARS-CoV-2 infection.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Celine Sze Ling Chui Research Topics

Disease

11	COVID-19 11/2022 - 01/2022
3	Bell Palsy (Bell's Palsy) 06/2022 - 01/2022
2	Myocarditis (Carditis) 12/2022 - 01/2022
2	Infections 01/2022 - 01/2022
2	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2022
1	Hemorrhagic Stroke 08/2022
1	Herpes Zoster 04/2022
1	Arthritis (Polyarthritis) 01/2022
1	Pericarditis 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Thromboembolism 01/2022
1	Neutropenia 01/2022
1	Rheumatoid Arthritis 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Hypothyroidism 01/2022
1	Leukopenia 01/2022

Drug/Important Bio-Agent (IBA)

14	BNT162 VaccineIBA 12/2022 - 01/2022
11	sinovac COVID-19 vaccineIBA 11/2022 - 01/2022
9	VaccinesIBA 12/2022 - 01/2022
8	Messenger RNA (mRNA)IBA 12/2022 - 01/2022
8	COVID-19 VaccinesIBA 12/2022 - 01/2022
5	insulin receptor-related receptor (IRR)IBA 12/2022 - 01/2022
1	TroponinIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022